Argentinean Registry on the Management of Helicobacter Pylori Infection
Launched by UNIVERSITY OF BUENOS AIRES · Aug 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Argentinean Registry on the Management of Helicobacter Pylori Infection, also known as ArgReg-Hp, is a clinical study aimed at understanding how to best treat Helicobacter pylori (H. pylori) infections, which can lead to stomach issues like gastritis and ulcers. With about half of the population in Argentina estimated to be infected, the study seeks to gather information from doctors about the different treatments they use in their everyday practice. By collecting this data, the researchers hope to identify effective treatments that can be used without needing to test each individual’s resistance to antibiotics, which can be complicated and time-consuming.
To participate in this study, you need to be an adult who has been diagnosed with an H. pylori infection. Unfortunately, pregnant or nursing women, or those who have taken antibiotics recently, cannot join. If you do participate, you can expect to contribute to a larger understanding of how H. pylori is treated in Argentina, which may help improve treatment for others in the future. The study is being conducted by several medical institutions and has received approval from ethical committees to ensure everything is done safely and responsibly.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infected adult patients by Helicobacter pylori
- • -
- Exclusion Criteria:
- • Pregnant or lactating women Subjects currently taking any antibiotics Administration of antibiotics or bismuth in the preceding 4 weeks or PPI 2 weeks previous Unable or refuse to give consent
About University Of Buenos Aires
The University of Buenos Aires (UBA) is a prestigious academic institution renowned for its commitment to advancing scientific research and promoting public health. As a clinical trial sponsor, UBA leverages its extensive expertise in various medical fields to facilitate innovative research initiatives aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university collaborates with a network of healthcare professionals, researchers, and institutions, ensuring rigorous adherence to ethical standards and regulatory requirements throughout the clinical trial process. UBA's dedication to academic excellence and community health positions it as a key player in the advancement of clinical research in Argentina and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ciudad De Buenos Aires, , Argentina
Patients applied
Trial Officials
Oscar M Laudanno, MD
Study Chair
Instituto de Investigaciones Médicas Alfredo Lanari. Universidad de Buenos Aires
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported